According to a recent market survey conducted by Future Market Insights (FMI), the global Surgical Drainage Devices Market was valued at US$ 1.3 billion in 2021 and is expected to reach US$ 2.9 billion by 2032. The market for Active Drains is expected to grow at a CAGR of 7.8% between 2022 and 2032. Between 2017 and 2021, the value of the Active Drains Market increased at a CAGR of around 6.7%.
Active drains are fluid collection systems that deposit fluid in reservoirs. These reservoirs limit the exposure of hospital workers to contaminated fluid. Active drains remove fluid from a wound or body cavity by using an artificial pressure gradient.
Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15869
Patients with active drains experienced 6% delayed healing, compared to 54% for those with passive drains, according to the National Library of Medicine.
Active drains have a significant impact on the outcome of cardiothoracic surgeries, particularly in children. As a result, the prevalence of chronic diseases such as arthritis and osteoporosis has increased, as has the use of active surgical drain devices among a diverse range of end-users. This appears to be driven primarily by significant advancements in the medical device industry.
Impact of Covid-19 on the Surgical Drainage Devices Market
The pandemic disrupted routine hospital services worldwide. During the pandemic, the hospital reduces the number of elective surgeries for patient safety. Reduced elective surgery protected patients from viral transmission, but it resulted in a drop in global demand for Surgical Drainage Devices. Over 20 million elective surgeries were cancelled during the pandemic, according to a report published in the British journal of surgery.
Top of Form
Bottom of Form
Competitive Landscape
Some of the key players in Surgical Drainage Devices include Acelity, Teleflex Incorporated, Cardinal Health, Medtronic, Cook Medical, Johnson and Johnson, B. Braun Melsungen AG, Smith & Nephew plc, Stryker, Becton Dickinson, and Centese.
Some of the recent developments of key surgical drains devices providers are as follows:
Centese developed a self-cleaning chest tube device in October 2021 that provides more accurate measurements for monitoring patients recovering from heart or lung surgery. Centese’s invention is known as the Thoraguard device. This device will assist Centese in accelerating its growth in the surgical drainage device segment.
Smith & Nephew plc announced the acquisition of Osiris Therapeutics, Inc. in April 2019. This acquisition will help Smith & Nephew’s surgical drains business grow even faster and advance the wound care franchise.
3M announced the acquisition of Acelity, Inc. in October 2019.
Surgical Drainage Devices Market Segmentation
By Product Type:
Active drains
Passive drains
By Application:
Thoracic and Cardiovascular Surgeries
Neurosurgical Procedures
Abdominal Surgery
Orthopedics
Other Applications
By End-Use:
Hospitals
Ambulatory Surgical Centers
Clinics
More Insights Available
Future Market Insights, in its new offering, presents an unbiased analysis of the Surgical Drainage Devices Market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.
The study reveals extensive growth in Surgical Drainage Devices Market in terms of Product Type (Active Drains, Passive Drains), Application (Thoracic and Cardiovascular Surgeries, Neurosurgical Procedures, Abdominal Surgery, Orthopedics, Other Applications.) by End use (Hospitals, Ambulatory Surgical Centers, Clinics) across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).